latisse

Latisse Faces Patent Challenge

July 13, 2010 · Posted in Daily Health News 

The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version.

See the original post:
Latisse Faces Patent Challenge

Comments

Leave a Reply